Water → 3,5-Diphenyl-4-[(2-methoxyethoxy)methoxy]-benzaldehyde

HRID 1067313

반응식

HRID 1067313 반응식
I[C:2]1[CH:3]=[C:4]([CH:7]=[C:8](I)[C:9]=1[O:10][CH2:11][O:12][CH2:13][CH2:14][O:15][CH3:16])[CH:5]=[O:6].[C:18]1(B(O)O)[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1.O>COCCOC.C([O-])(=O)C.[Pd+2].C([O-])(=O)C>[CH3:16][O:15][CH2:14][CH2:13][O:12][CH2:11][O:10][C:9]1[C:8]([C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)=[CH:7][C:4]([CH:5]=[O:6])=[CH:3][C:2]=1[C:2]1[CH:3]=[CH:4][CH:7]=[CH:8][CH:9]=1

참가 물질

6

반응물 3

HCID 962WaterHCID 66827Phenylboronic AcidHCID 222376563,5-Diiodo-4-(2-methoxyethoxymethoxy)benzaldehyde

생성물 1

HCID 222375093,5-Diphenyl-4-[(2-methoxyethoxy)methoxy]-benzaldehyde수율 57%

시약·촉매·용매 2

HCID 167845palladium(II) acetate촉매HCID 80711,2-Dimethoxyethane용매

실험 절차

The title compound was prepared according to the procedure in Example 2, step 3 using 3,5-diiodo-4-(2-methoxyethoxymethoxy)benzaldehyde (4.029 g, 8.721 mmol), phenylboronic acid (2.339 g, 19.19 mrnmol), palladium(II) acetate (39.16 mg, 0.174 mmol) in DME:H2O. Purification on Biotage KP-Sil eluting with 15% EtOAc/pet. ether gave 1.803 g, (57%) of the title compound. 1H NMR (DMSO-d6) δ2.78-2.82 (m, 2H), 2.89-2.92 (m, 2H), 3.01 (s, 3H), 4,42 (s, 2H), 7.40-7.54 (m, 6H), 7.62-7.65 (m, 4H), 7.91 (s, 2H), 10.06 (s, 1H).

후처리

  1. customThe title compound was prepared
  2. customPurification on Biotage KP-Sil
  3. washeluting with 15% EtOAc/pet. ether

출처 및 근거

ORD 기록
ord-02437f5098554952a978bf51e4530ed5
출처 데이터셋
uspto-grants-2001_06
특허 번호
US06248764B1

연결된 노트

불러오는 중…